Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

- PMLiVE

Envision Pharma Group announces changes in its executive team

Current CEO Brian Hepburn will be succeeded by CCO David Thompson

- PMLiVE

Sciterion appoints Gabi Cutayar as new MD

Previously served as business director at McCann Health

- PMLiVE

Behavioural Science in Healthcare

Personal health and wellbeing has never been more a part of the public conscious than it is now.

Page & Page Health

- PMLiVE

Why aren’t doctors using digital therapeutics?

The digital therapeutics market is set to reach almost $1 billion by 2026 as wearables and apps continue to play an important role in enhancing healthcare. However, adoption of these...

Blue Latitude Health

- PMLiVE

Biogen scores mid-stage trial win for lupus drug BIIB059

Last approved treatment for Lupus was GSK's Benlysta in 2011

Bristol Myers Squibb logo

BMS, Acceleron Pharma’s Reblozyl to be reviewed by FDA expert panel

Could win approval in group of rare blood cancers

- PMLiVE

Two new senior hires announced at Ashfield

Gregg Flynn and Colin Stanley will serve as global presidents

- PMLiVE

Seattle Genetics moves to dismiss ADC lawsuit with Daiichi Sankyo

US-based biotech is arguing the legal action is improper

- PMLiVE

Astellas makes gene therapy a core focus with $3bn Audentes buy

Deal includes a late-stage candidate for a rare disease

Mythical creatures and marketing – an unlikely combination

By Jess Baldock

- PMLiVE

ABPI appoints industry veteran Richard Torbett as new chief executive

Torbett initially joined the pharma association in March 2016

AstraZeneca AZ

AstraZeneca divests Seroquel rights to focus on key therapy areas

Second divestment to Germany-based Cheplapharm this year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links